dansylglutamyl-glycyl-arginine chloromethyl ketone has been researched along with fibrin in 2 studies
| Studies (dansylglutamyl-glycyl-arginine chloromethyl ketone) | Trials (dansylglutamyl-glycyl-arginine chloromethyl ketone) | Recent Studies (post-2010) (dansylglutamyl-glycyl-arginine chloromethyl ketone) | Studies (fibrin) | Trials (fibrin) | Recent Studies (post-2010) (fibrin) |
|---|---|---|---|---|---|
| 31 | 0 | 0 | 15,994 | 328 | 3,808 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Husain, SS | 1 |
| Meixner, SC; Pryzdial, EL; Talbot, K | 1 |
2 other study(ies) available for dansylglutamyl-glycyl-arginine chloromethyl ketone and fibrin
| Article | Year |
|---|---|
Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
Topics: Amino Acid Chloromethyl Ketones; Animals; Cricetinae; Cricetulus; Dansyl Compounds; Enzyme Precursors; Female; Fibrin; Fibrinolysin; Fibrinolytic Agents; Humans; Hydrolysis; Isoflurophate; Kidney; Oligopeptides; Ovary; Plasminogen Activators; Recombinant Proteins; Substrate Specificity; Urokinase-Type Plasminogen Activator | 1991 |
Enhanced fibrinolysis by proteolysed coagulation factor Xa.
Topics: Amino Acid Chloromethyl Ketones; Catalytic Domain; Dansyl Compounds; Factor Xa; Factor Xa Inhibitors; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Fibrinolysis; Humans; In Vitro Techniques; Models, Biological; Peptide Fragments; Peptide Hydrolases; Protein Structure, Tertiary; Tissue Plasminogen Activator | 2010 |